NASDAQ : MCTA
Charming Medical Limited — Financial statements
Healthcare · Medical Care Facilities · Hong Kong
Last price 29.11 USD (Nov 11, 2025, 4:00 PM EDT) · Market cap 504.26M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Financial statements
Charming Medical Limited (MCTA) reported revenue of 4.81M USD (TTM). Five years of income statement, balance sheet, cash flow and ratios below.
Income statement
Fiscal year April - March; amounts in USD.
| TTM | FY2026 | FY2025 | FY2024 | FY2023 | |
|---|---|---|---|---|---|
| Revenue | 4.81M | 4.81M | 6.22M | 6.02M | 3.53M |
| Cost of Revenue | 175.05K | 175.05K | 201.62K | 170.49K | 47.42K |
| Gross Profit | 4.63M | 4.63M | 6.02M | 5.84M | 3.48M |
| Selling, General & Admin | 4.31M | 4.31M | 4.16M | 4.28M | 3.65M |
| Operating Expenses | 4.52M | 4.52M | 4.42M | 4.67M | 3.86M |
| Operating Income | 108.51K | 108.51K | 1.60M | 1.17M | -379.02K |
| Interest Expense | -15.80K | -15.80K | -20.87K | -26.05K | -20.26K |
| Interest & Investment Income | 72.65K | 72.65K | 64.14K | 19.51K | 10.29K |
| Other Non Operating Income (Expenses) | -66.62K | -66.62K | -210.34K | -162.53K | -31.47K |
| EBT Excluding Unusual Items | 98.74K | 98.74K | 1.43M | 1.00M | -420.47K |
| Gain (Loss) on Sale of Investments | 34.72K | 34.72K | 2.62K | ||
| Pretax Income | 133.47K | 133.47K | 1.44M | 1.00M | -420.47K |
| Income Tax Expense | 156.11K | 156.11K | 236.08K | 181.75K | -84.86K |
| Earnings From Continuing Operations | -22.65K | -22.65K | 1.20M | 821.74K | -335.61K |
| Minority Interest in Earnings | -43.93K | 30.49K | |||
| Net Income | -22.65K | -22.65K | 1.20M | 777.81K | -305.12K |
| Net Income to Common | -22.65K | -22.65K | 1.20M | 777.81K | -305.12K |
| Shares Outstanding (Basic) | 16.15M | 16.15M | 15.34M | 15.34M | 15.34M |
| Shares Outstanding (Diluted) | 16.15M | 16.15M | 15.34M | 15.34M | 15.34M |
| EPS (Basic) | -0.00 | -0.00 | 0.08 | 0.05 | -0.02 |
| EPS (Diluted) | -0.00 | -0.00 | 0.08 | 0.05 | -0.02 |
| Free Cash Flow | -1.56M | -1.56M | 138.36K | 84.83K | 1.83M |
| Free Cash Flow Per Share | -0.10 | -0.10 | 0.01 | 0.01 | 0.12 |
| Gross Margin | 96.36% | 96.36% | 96.76% | 97.17% | 98.66% |
| Operating Margin | 2.26% | 2.26% | 25.71% | 19.49% | -10.73% |
| Profit Margin | -0.47% | -0.47% | 19.27% | 12.93% | -8.64% |
| Free Cash Flow Margin | -32.35% | -32.35% | 2.22% | 1.41% | 51.76% |
| EBITDA | 324.58K | 324.58K | 1.86M | 1.56M | -167.95K |
| EBITDA Margin | 6.75% | 6.75% | 29.95% | 26.00% | -4.76% |
| D&A For EBITDA | 216.07K | 216.07K | 263.45K | 391.70K | 211.08K |
| EBIT | 108.51K | 108.51K | 1.60M | 1.17M | -379.02K |
| EBIT Margin | 2.26% | 2.26% | 25.71% | 19.49% | -10.73% |
| Effective Tax Rate | 116.97% | 116.97% | 16.45% | 18.11% | |
| Revenue as Reported | 4.81M | 4.81M | 6.22M | 6.02M | 3.53M |
| Advertising Expenses | 803.48K | 803.48K | 999.35K | 859.47K | 664.88K |
Balance sheet
Fiscal year April - March; amounts in USD.
| TTM | FY2026 | FY2025 | FY2024 | FY2023 | |
|---|---|---|---|---|---|
| Cash & Equivalents | 4.70M | 4.70M | 816.77K | 2.10M | 1.93M |
| Short-Term Investments | 2.46M | 2.46M | 1.62M | 295.02K | |
| Trading Asset Securities | 511.13K | 511.13K | 503.45K | ||
| Cash & Short-Term Investments | 7.68M | 7.68M | 2.94M | 2.40M | 1.93M |
| Accounts Receivable | 201.48K | 201.48K | 395.90K | 351.61K | 186.64K |
| Other Receivables | 2.48K | 2.48K | 1.56K | 3.93K | 1.82M |
| Receivables | 203.96K | 203.96K | 397.46K | 355.54K | 2.00M |
| Inventory | 25.62K | 25.62K | 26.80K | 28.15K | 66.33K |
| Prepaid Expenses | 19.95K | ||||
| Other Current Assets | 270.00K | 270.00K | 885.06K | 99.42K | |
| Total Current Assets | 8.17M | 8.17M | 3.37M | 3.67M | 4.12M |
| Property, Plant & Equipment | 1.33M | 1.33M | 1.21M | 921.86K | 1.80M |
| Long-Term Deferred Tax Assets | 9.03K | 9.03K | 77.29K | 211.14K | 272.77K |
| Long-Term Deferred Charges | 572.35K | 26.83K | |||
| Other Long-Term Assets | 354.02K | 354.02K | 128.29K | 54.60K | 193.75K |
| Total Assets | 9.87M | 9.87M | 5.36M | 4.88M | 6.38M |
| Accounts Payable | 26.64K | 26.64K | 218.08K | 1.57K | |
| Accrued Expenses | 364.28K | 364.28K | 206.28K | 411.14K | 228.07K |
| Short-Term Debt | 185.80K | 185.80K | 314.23K | 442.61K | 589.66K |
| Current Portion of Leases | 366.66K | 366.66K | 488.38K | 370.52K | 735.60K |
| Current Income Taxes Payable | 307.37K | 307.37K | 221.34K | 119.25K | |
| Current Unearned Revenue | 3.05M | 3.05M | 3.46M | 4.50M | 5.60M |
| Other Current Liabilities | 33.82K | 33.82K | 36.70K | 40.01K | 11.23K |
| Total Current Liabilities | 4.33M | 4.33M | 4.95M | 5.88M | 7.17M |
| Long-Term Leases | 355.56K | 355.56K | 358.03K | 148.25K | 484.26K |
| Total Liabilities | 4.69M | 4.69M | 5.31M | 6.03M | 7.65M |
| Common Stock | 1.72K | 1.72K | 1.53K | 1.53K | 1.53K |
| Additional Paid-In Capital | 5.10M | 5.10M | 312.88K | 379.51K | 379.51K |
| Retained Earnings | 96.79K | 96.79K | 119.44K | -1.08M | -1.16M |
| Comprehensive Income & Other | -14.79K | -14.79K | -384.61K | -380.84K | -377.12K |
| Total Common Equity | 5.18M | 5.18M | 49.24K | -1.08M | -1.16M |
| Minority Interest | -66.63K | -110.21K | |||
| Shareholders' Equity | 5.18M | 5.18M | 49.24K | -1.15M | -1.27M |
| Total Liabilities & Equity | 9.87M | 9.87M | 5.36M | 4.88M | 6.38M |
| Total Debt | 908.02K | 908.02K | 1.16M | 961.38K | 1.81M |
| Net Cash (Debt) | 6.77M | 6.77M | 1.78M | 1.44M | 119.68K |
| Net Cash Per Share | 0.42 | 0.42 | 0.12 | 0.09 | 0.01 |
| Filing Date Shares Outstanding | 17.18M | 17.18M | 15.34M | 15.34M | 15.34M |
| Total Common Shares Outstanding | 17.18M | 17.18M | 15.34M | 15.34M | 15.34M |
| Working Capital | 3.84M | 3.84M | -1.58M | -2.21M | -3.05M |
| Book Value Per Share | 0.30 | 0.30 | 0.00 | -0.07 | -0.08 |
| Tangible Book Value | 5.18M | 5.18M | 49.24K | -1.08M | -1.16M |
| Tangible Book Value Per Share | 0.30 | 0.30 | 0.00 | -0.07 | -0.08 |
| Machinery | 922.59K | 922.59K | 659.47K | 369.27K | 201.91K |
| Leasehold Improvements | 528.68K | 528.68K | 724.40K | 798.53K | 752.41K |
Cash flow statement
Fiscal year April - March; amounts in USD.
| TTM | FY2026 | FY2025 | FY2024 | FY2023 | |
|---|---|---|---|---|---|
| Net Income | -22.65K | -22.65K | 1.20M | 777.81K | -305.12K |
| Depreciation & Amortization | 216.07K | 216.07K | 263.45K | 391.70K | 211.08K |
| Loss (Gain) From Sale of Assets | -11.80K | -11.80K | |||
| Loss (Gain) From Sale of Investments | -22.62K | -22.62K | -2.62K | ||
| Other Operating Activities | 44.10K | 44.10K | 126.61K | 68.96K | 30.41K |
| Change in Accounts Receivable | 194.42K | 194.42K | -44.29K | -164.98K | -154.02K |
| Change in Inventory | 1.17K | 1.17K | 1.35K | 38.18K | -55.87K |
| Change in Accounts Payable | 168.84K | 168.84K | -204.69K | 210.28K | 180.40K |
| Change in Unearned Revenue | -415.87K | -415.87K | -1.06M | -1.11M | 2.73M |
| Change in Income Taxes | 86.03K | 86.03K | 102.08K | 119.25K | |
| Change in Other Net Operating Assets | -1.45M | -1.45M | 42.08K | -39.27K | -113.83K |
| Operating Cash Flow | -1.22M | -1.22M | 425.89K | 295.43K | 2.43M |
| Capital Expenditures | -339.56K | -339.56K | -287.53K | -210.60K | -606.19K |
| Sale of Property, Plant & Equipment | 30.50K | 30.50K | |||
| Investment in Securities | 130.05K | 130.05K | -1.94M | ||
| Investing Cash Flow | -179.01K | -179.01K | -2.23M | -210.60K | -606.19K |
| Short-Term Debt Issued | 671.61K | 671.61K | 1.20M | 1.54M | |
| Long-Term Debt Issued | 205.87K | 38.34K | |||
| Total Debt Issued | 671.61K | 671.61K | 1.41M | 1.58M | |
| Short-Term Debt Repaid | -1.00M | -1.00M | -314.90K | -1.44M | -177.92K |
| Long-Term Debt Repaid | -113.83K | -113.83K | -26.15K | -5.31K | |
| Total Debt Repaid | -1.12M | -1.12M | -341.06K | -1.45M | -177.92K |
| Net Debt Issued (Repaid) | -445.78K | -445.78K | 1.07M | 126.98K | -177.92K |
| Issuance of Common Stock | 6.91M | 6.91M | |||
| Other Financing Activities | -1.18M | -1.18M | -545.52K | -26.83K | -1.25M |
| Financing Cash Flow | 5.29M | 5.29M | 521.30K | 100.14K | -1.43M |
| Foreign Exchange Rate Adjustments | -14.71K | -14.71K | -4.62K | -10.51K | 5.66K |
| Net Cash Flow | 3.88M | 3.88M | -1.29M | 174.46K | 402.99K |
| Free Cash Flow | -1.56M | -1.56M | 138.36K | 84.83K | 1.83M |
| Free Cash Flow Margin | -32.35% | -32.35% | 2.22% | 1.41% | 51.76% |
| Free Cash Flow Per Share | -0.10 | -0.10 | 0.01 | 0.01 | 0.12 |
| Levered Free Cash Flow | -507.04K | -507.04K | 886.44K | 1.04M | |
| Unlevered Free Cash Flow | -497.17K | -497.17K | 899.49K | 1.06M | |
| Cash Interest Paid | 15.80K | 15.80K | 20.87K | 26.05K | 20.26K |
| Change in Working Capital | -1.42M | -1.42M | -1.16M | -943.05K | 2.50M |
Ratios
Fiscal year April - March; amounts in USD.
| TTM | FY2026 | FY2025 | FY2024 | FY2023 | |
|---|---|---|---|---|---|
| Market Capitalization | 504.26M | 504.26M | |||
| Enterprise Value | 502.48M | 502.15M | |||
| Last Close Price | 29.36 | ||||
| PS Ratio | 104.89 | 104.89 | |||
| PB Ratio | 97.33 | 97.33 | |||
| P/TBV Ratio | 97.33 | 97.33 | |||
| EV/Sales Ratio | 104.51 | 104.45 | |||
| EV/EBITDA Ratio | 1,548.07 | 1,547.05 | |||
| EV/EBIT Ratio | 4,630.75 | 4,627.70 | |||
| Debt / Equity Ratio | 0.17 | 0.17 | 23.57 | -0.84 | -1.43 |
| Debt / EBITDA Ratio | 1.04 | 1.04 | 0.45 | 0.40 | 3.77 |
| Debt / FCF Ratio | 8.39 | 11.33 | 0.99 | ||
| Net Debt / Equity Ratio | -1.31 | -1.31 | -36.19 | 1.25 | 0.09 |
| Net Debt / EBITDA Ratio | -20.85 | -20.85 | -0.96 | -0.92 | 0.71 |
| Net Debt / FCF Ratio | 4.35 | 4.35 | -12.88 | -16.94 | -0.07 |
| Asset Turnover | 0.63 | 0.63 | 1.22 | 1.07 | |
| Inventory Turnover | 6.68 | 6.68 | 7.34 | 3.61 | |
| Quick Ratio | 1.82 | 1.82 | 0.68 | 0.47 | 0.55 |
| Current Ratio | 1.89 | 1.89 | 0.68 | 0.62 | 0.57 |
| Return on Equity (ROE) | -0.87% | -0.87% | |||
| Return on Assets (ROA) | 0.89% | 0.89% | 19.53% | 13.01% | |
| Return on Capital Employed (ROCE) | 2.00% | 2.00% | 392.80% | -117.50% | 48.30% |
| Earnings Yield | -0.00% | -0.00% | |||
| FCF Yield | -0.31% | -0.31% | |||
| Buyback Yield / Dilution | -5.29% | -5.29% |